Titan receives FDA approval

New Product Receives FDA Clearance BRISBANE, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Cutera, Inc. (Nasdaq: CUTR), a leading manufacturer of laser and other light-based aesthetic systems, is introducing a new platform design for aesthetic systems. The first application available in this tabletop platform is the new and exciting Titan procedure. Titan, Cutera's latest product offering, is a light-based system that targets the dermis and provides sustained heating to the deep layers of the skin while simultaneously protecting the epidermis.

Commenting on the announcement, Cutera President and Chief Executive Officer Kevin Connors said, "We are very excited about the interest that Titan has generated. Titan had been available only on our Xeo platform, Cutera's multipurpose device for skin rejuvenation, hair removal and vascular treatments. The new Titan platform offers another choice to physicians who want to expand their practice with an exciting new application."

The FDA has cleared the Titan to be marketed to aesthetic professionals in the new tabletop platform and is now available for sale. The Titan on the Xeo platform received Canadian approval in June, 2004 and received the CE Mark in Europe in April, 2004.

About CUTERA

Brisbane, Calif.-based Cutera is one of the world's leading providers of laser and other light-based aesthetic systems to the professional aesthetic market. Since 1998, Cutera (formerly Altus Medical) has developed innovative, easy-to-use products that enable dermatologists, plastic surgeons, gynecologists, primary care physicians and other qualified practitioners to offer safe, effective and non-invasive aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com